Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by Strathroy50on May 23, 2007 4:38pm
545 Views
Post# 12827605

CC winner for the Day

CC winner for the Day...with a net buy of 38,100 shares for the day !! Here are all the house positions for T: RVX for 5/23/2007. 19 Records Returned House Positions Exch House Bought $Value Ave Sold $Value Ave Net $Net T 33 Canaccord 38,600 691,846 17.92 500 8,975 17.95 38,100 -682,871 T 1 Anonymous 17,200 308,492 17.94 10,200 183,277 17.97 7,000 -125,215 T 27 Dundee 7,539 133,361 17.69 3,600 64,100 17.81 3,939 -69,261 T 2 RBC 4,100 73,664 17.97 1,500 26,985 17.99 2,600 -46,679 T 13 Instinet 700 12,571 17.96 0 700 -12,571 T 124 Questrade 300 5,376 17.92 0 300 -5,376 T 85 Scotia 475 8,550 18.00 200 3,540 17.70 275 -5,010 T 9 BMO Nesbitt 800 14,364 17.96 600 10,770 17.95 200 -3,594 T 88 E-TRADE 2,500 45,000 18.00 2,400 43,077 17.95 100 -1,923 T 58 Nomura 50 915 18.30 0 50 -915 T 89 Raymond James 9 159 17.67 414 7,414 17.91 -405 7,255 T 80 National Bank 0 500 8,910 17.82 -500 8,910 T 83 Research Cap 0 1,000 17,900 17.90 -1,000 17,900 T 79 CIBC 1,850 33,100 17.89 3,600 64,753 17.99 -1,750 31,653 T 14 ITG 0 2,000 35,980 17.99 -2,000 35,980 T 7 TD Sec 1,700 30,476 17.93 7,909 141,664 17.91 -6,209 111,188 T 62 Haywood 0 10,000 175,712 17.57 -10,000 175,712 T 46 Blackmont 0 13,100 235,417 17.97 -13,100 235,417 T 75 MGI 0 18,300 329,400 18.00 -18,300 329,400 Total 75,823 1,357,874 17.91 75,823 1,357,874 17.91 0 0
Bullboard Posts